On June 14, 2026, Enhanced Group Inc. entered into a securities purchase agreement for a private placement of 12,853,468 shares of Class A common stock and an equal number of accompanying warrants. The combined purchase price is $3.89 per share and warrant, with expected gross proceeds of approximately $50.0 million. The placement will close in three tranches, starting June 17, 2026. Proceeds will be used to repay a Working Capital Promissory Note to Apeiron Investment Group Limited and for general corporate purposes, including the growth of its telehealth and consumer health platform. The warrants have an exercise price of $3.89 and a five-year term, with an accelerated expiration if the stock price reaches $20.00 for 20 consecutive trading days. The company operates in the healthcare industry, providing a telehealth and consumer health platform.